Cigna Investments’s Vanda Pharmaceuticals VNDA Stock Holding History

Cigna Investments’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-18,398	Closed	-$191K	–	799
2020 Q1	$191K	Buy	+18,398	New	+$228K	0.02%	561

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Cigna Investments's VNDA Position: Q2 2020 in Review

Cigna Investments sold out of Vanda Pharmaceuticals (VNDA) in Q2 2020, closing a stake of 18,398 shares — an estimated $191K sold.

Cigna Investments first reported a position in VNDA in Q1 2020 and held it in 1 quarter. The position peaked at $191K in Q1 2020. 164 funds tracked by Wall St. Rank hold VNDA as of Q2 2020.

Cigna Investments reported no remaining Vanda Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
Cigna Investments sold 18,398 Vanda Pharmaceuticals shares in Q2 2020, an estimated $191K.
Cigna Investments first reported a position in Vanda Pharmaceuticals in Q1 2020 and held it in 1 quarter.
Cigna Investments's Vanda Pharmaceuticals position peaked at $191K in Q1 2020.
164 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2020.

Based on Cigna Investments's 13F filing for Q2 2020, filed 17 Aug 2020.